Cargando…

The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme

AIMS: We aimed to use longitudinal data from an established screening programme with good quality assurance and quality control procedures and a stable well‐trained workforce to determine the accuracy of grading in diabetic retinopathy screening. METHODS: We used a continuous time‐hidden Markov mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Oke, J. L., Stratton, I. M., Aldington, S. J., Stevens, R. J., Scanlon, P. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019246/
https://www.ncbi.nlm.nih.gov/pubmed/26666463
http://dx.doi.org/10.1111/dme.13053
_version_ 1782453022428758016
author Oke, J. L.
Stratton, I. M.
Aldington, S. J.
Stevens, R. J.
Scanlon, P. H.
author_facet Oke, J. L.
Stratton, I. M.
Aldington, S. J.
Stevens, R. J.
Scanlon, P. H.
author_sort Oke, J. L.
collection PubMed
description AIMS: We aimed to use longitudinal data from an established screening programme with good quality assurance and quality control procedures and a stable well‐trained workforce to determine the accuracy of grading in diabetic retinopathy screening. METHODS: We used a continuous time‐hidden Markov model with five states to estimate the probability of true progression or regression of retinopathy and the conditional probability of an observed grade given the true grade (misclassification). The true stage of retinopathy was modelled as a function of the duration of diabetes and HbA(1c). RESULTS: The modelling dataset consisted of 65 839 grades from 14 187 people. The median number [interquartile range (IQR)] of examinations was 5 (3, 6) and the median (IQR) interval between examinations was 1.04 (0.99, 1.17) years. In total, 14 227 grades (21.6%) were estimated as being misclassified, 10 592 (16.1%) represented over‐grading and 3635 (5.5%) represented under‐grading. There were 1935 (2.9%) misclassified referrals, 1305 were false‐positive results (2.2%) and 630 were false‐negative results (11.0%). Misclassification of background diabetic retinopathy as no detectable retinopathy was common (3.4% of all grades) but rarely preceded referable maculopathy or retinopathy. CONCLUSION: Misclassification between lower grades of retinopathy is not uncommon but is unlikely to lead to significant delays in referring people for sight‐threatening retinopathy.
format Online
Article
Text
id pubmed-5019246
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50192462016-09-23 The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme Oke, J. L. Stratton, I. M. Aldington, S. J. Stevens, R. J. Scanlon, P. H. Diabet Med Research Articles AIMS: We aimed to use longitudinal data from an established screening programme with good quality assurance and quality control procedures and a stable well‐trained workforce to determine the accuracy of grading in diabetic retinopathy screening. METHODS: We used a continuous time‐hidden Markov model with five states to estimate the probability of true progression or regression of retinopathy and the conditional probability of an observed grade given the true grade (misclassification). The true stage of retinopathy was modelled as a function of the duration of diabetes and HbA(1c). RESULTS: The modelling dataset consisted of 65 839 grades from 14 187 people. The median number [interquartile range (IQR)] of examinations was 5 (3, 6) and the median (IQR) interval between examinations was 1.04 (0.99, 1.17) years. In total, 14 227 grades (21.6%) were estimated as being misclassified, 10 592 (16.1%) represented over‐grading and 3635 (5.5%) represented under‐grading. There were 1935 (2.9%) misclassified referrals, 1305 were false‐positive results (2.2%) and 630 were false‐negative results (11.0%). Misclassification of background diabetic retinopathy as no detectable retinopathy was common (3.4% of all grades) but rarely preceded referable maculopathy or retinopathy. CONCLUSION: Misclassification between lower grades of retinopathy is not uncommon but is unlikely to lead to significant delays in referring people for sight‐threatening retinopathy. John Wiley and Sons Inc. 2016-01-10 2016-07 /pmc/articles/PMC5019246/ /pubmed/26666463 http://dx.doi.org/10.1111/dme.13053 Text en © 2015 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Oke, J. L.
Stratton, I. M.
Aldington, S. J.
Stevens, R. J.
Scanlon, P. H.
The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
title The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
title_full The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
title_fullStr The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
title_full_unstemmed The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
title_short The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
title_sort use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019246/
https://www.ncbi.nlm.nih.gov/pubmed/26666463
http://dx.doi.org/10.1111/dme.13053
work_keys_str_mv AT okejl theuseofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT strattonim theuseofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT aldingtonsj theuseofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT stevensrj theuseofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT scanlonph theuseofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT okejl useofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT strattonim useofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT aldingtonsj useofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT stevensrj useofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme
AT scanlonph useofstatisticalmethodologytodeterminetheaccuracyofgradingwithinadiabeticretinopathyscreeningprogramme